{"text": "stifel initiated aclx buy43 jnj amp legn carvykti autologous bcma tgt g car t sets efficacy bar4the class in mm but mfg challenges have limited adoption opens door4comp like arcellx whose lead cart ddbcma p ship w gild has shown akin efficacy in arguably a tougher pt pop xbi"}
{"text": "even if a viral hotspot mutation tcr t company figures out how to do it better than tcrt kite gild could not nor many others so far from rhhby to bmy or azn you dont think the first company to dose a tcr t with precision 60 to 100 billion tcr t cells could do better"}
{"text": "wow expectations have really taken a dive in these orphan drug days anyone remember gilds first quarter sovaldi sales something like 2 3bn now that was a blowout"}
{"text": "gild goes ex div tomorrow for 0 75 it has increased its div 3 times in 3 years annual yld is 3 8"}
{"text": "arcellx initiated with a buy at stifel aclx jnj legn gild"}
{"text": "dividends happening tomorrow 2023 03 14 mrk tmo gild vale lrcx"}
